INFAI products for various gastrointestinal,
metabolic and cardiovascular diseases

Our products

We offer you a range of products for various gastrointestinal, metabolic and cardiovascular diseases

Helicobacter Test INFAI

Helicobacter Test INFAI is a ¹³C-urea breath test for the direct, non-invasive detection of the bacterium Helicobacter pylori.

Metabo Test INFAI

Urinary metabolite screening for diagnosing metabolic diseases in newborns and children. The test is evaluated by NMR spectroscopy.

Cardio Test INFAI

Lipoprotein analysis in serum for risk assessment of cardiovascular diseases. The test is evaluated by NMR spectroscopy.

Clinical Studies

INFAI offers pharmaceutical companies clinical studies with the following products (Helicobacter Test INFAI, Gastromotal, Pancreo-Lip).

Advantages of INFAI breath tests

Non-invasive

Breath tests are non-invasive and are considered the gold standard in diagnosing various diseases.

Simple test performance

The tests are easy to perform, there are no inconveniences as with endoscopic examinations.
P

High sensitivity and specificity

The sensitivity and specificity of breath tests often exceed conventional methods.
'

Significant cost reduction

Healthcare costs are significantly reduced when breath testing replaces endoscopy and biopsy.

About us

INFAI specializes in the transfer of advanced analytical technology in the field of medical diagnostics and the development of innovative pharmaceutical products. The company is a pioneer in the use of stable isotopes compounds with IRMS and NMR spectrometer in field of gastroenterology, oncology and metabolic diseases. INFAI’s laboratories in Bochum, Germany and York in United Kingdom are equipped with state-of-the-art instruments. These facilities are used for internal research and product development, but are also available for collaborations and contract research.

Read more

Innovations from INFAI

INFAI has developed a number of different innovative products in recent years that are used to study gastrointestinal and cardiovascular diseases as well as metabolic disorders. INFAI’s laboratories are used for internal research and product development, but are also available for collaborative and contract research. Over the past 10 years, a number of non-invasive, highly efficient stable isotope breath tests (Helicobacter Test, Gastromotal, Pancreo-Lip, Lactoin) have been developed. Some of these products have already been approved by EMA.

Read more